Featured Research

from universities, journals, and other organizations

Faulty energy production in brain cells leads to disorders ranging from Parkinson's to intellectual disability

Date:
May 16, 2013
Source:
VIB
Summary:
Neuroscientists have shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities. The link between dysfunctional mitochondria and Parkinson's disease is known, but this new research shows that it is also present in other brain disorders.

Neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven has shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities. The link between dysfunctional mitochondria and Parkinson's disease is known, but this new research shows that it is also present in other brain disorders.

Patrik Verstreken (VIB / KU Leuven): "This discovery shows that energy production in brain cells is the basis of various brain disorders. We hope that a better understanding of the mechanisms used by the cell to maintain optimum energy levels will lead in the long term to medical applications that prevent or cure these diseases."

Dysfunctional mitochondria toxic for the brain cell

Well-functioning mitochondria -- the organelles that generate energy in cells -- are essential for a healthy brain. They provide the energy needed for communication between brain cells, which is crucial for transmitting stimuli and signals and thus for optimal functioning of the body. Earlier research has shown that Parkinson's disease is often paired with dysfunctional mitochondria. Moreover, dysfunctional mitochondria are not efficiently discarded from the cell, which complicates the operation of other healthy mitochondria and leads to insufficient energy production in the cell. They can be compared to a faulty engine that emits toxic fumes.

Quality control by the brain cell

The Leuven-based VIB researchers Dominik Haddad, Vanessa Morais and Patrik Verstreken have unraveled the mechanism by which brain cells trigger the destruction of dysfunctional mitochondria. Once the mechanism is triggered, communication between brain cells is reestablished. The researchers were surprised to find that this mechanism is not only defective in Parkinson's disease, but also in specific cases of intellectual disability. These results indicate the wider importance of mitochondria for optimal functioning of our brains. Haddad, Morais and Verstreken hope that their insights eventually contribute to the prevention of various brain disorders.

Brain disorders in Europe

1 in 3 Europeans will suffer from a brain disorder during his or her lifetime. All of us know people with dementia, schizophrenia, intellectual disability or another brain condition. Each of these diseases penetrates to a person's core and have a huge impact on the patient and his or her family. They also carry an economic impact: €800 billion is spent each year in Europe to cover brain disorder-related health needs.

Bart De Strooper (VIB/KU Leuven): "The brain is decisive in shaping who we are, but from a scientific standpoint, it is uncharted territory. This research constitutes an important piece of the complex puzzle. Brain research is vital, especially because brain disorders weigh so heavily on patients, their families and society. I am delighted that May 2013 has been designated the European Month of the Brain."


Story Source:

The above story is based on materials provided by VIB. Note: Materials may be edited for content and length.


Journal Reference:

  1. DominikM. Haddad, Sven Vilain, Melissa Vos, Giovanni Esposito, Samer Matta, VeraM. Kalscheuer, Katleen Craessaerts, Maarten Leyssen, RafaellaM.P. Nascimento, AngelaM. Vianna-Morgante, Bart DeStrooper, Hilde VanEsch, VanessaA. Morais, Patrik Verstreken. Mutations in the Intellectual Disability Gene Ube2a Cause Neuronal Dysfunction and Impair Parkin-Dependent Mitophagy. Molecular Cell, 2013; DOI: 10.1016/j.molcel.2013.04.012

Cite This Page:

VIB. "Faulty energy production in brain cells leads to disorders ranging from Parkinson's to intellectual disability." ScienceDaily. ScienceDaily, 16 May 2013. <www.sciencedaily.com/releases/2013/05/130516123804.htm>.
VIB. (2013, May 16). Faulty energy production in brain cells leads to disorders ranging from Parkinson's to intellectual disability. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/05/130516123804.htm
VIB. "Faulty energy production in brain cells leads to disorders ranging from Parkinson's to intellectual disability." ScienceDaily. www.sciencedaily.com/releases/2013/05/130516123804.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins